I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
0.8850
+0.0027 (0.31%)
At close: May 15, 2025, 4:00 PM
0.8818
-0.0032 (-0.36%)
After-hours: May 15, 2025, 4:10 PM EDT
I-Mab Market Cap
I-Mab has a market cap or net worth of $72.13 million as of May 15, 2025. Its market cap has decreased by -50.35% in one year.
Market Cap
72.13M
Enterprise Value
-96.98M
1-Year Change
-50.35%
Ranking
Category
Stock Price
$0.89
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has decreased from $138.05M to $72.13M, a decrease of -47.75%. That is a compound annual growth rate of -11.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2025 | 71.91M | 3.88% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.76B |
| Johnson & Johnson | 357.16B |
| AbbVie | 332.08B |
| Novo Nordisk | 291.59B |
| UnitedHealth Group | 282.47B |
| Abbott Laboratories | 224.53B |
| Novartis AG | 209.81B |
| AstraZeneca | 209.59B |